GENB (Generate Biomedicines) Total Assets: $330.18 Mil (As of Dec. 2025)


GENB Generate Biomedicines Inc GENB
6 GF Score
Price $16.92
! 2 Warning Signs
View Full Analysis

What is Generate Biomedicines Total Assets?

Generate Biomedicines GENB +2.18% 6 Total Assets is $330.18 Mil as of Dec. 2025. GuruFocus rates GENB with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Generate Biomedicines's Total Assets for the quarter that ended in Dec. 2025 was $330.18 Mil.

During the past 12 months, Generate Biomedicines's average Total Assets Growth Rate was -12.80% per year.

Total Assets is connected with ROA %. Generate Biomedicines's annualized ROA % for the quarter that ended in Dec. 2025 was -47.89%. Total Assets is also linked to Revenue through Asset Turnover. Generate Biomedicines's Asset Turnover for the quarter that ended in Dec. 2025 was 0.08.

Generate Biomedicines  (NAS:GENB) Total Assets Explanation

Total Assets is connected with ROA %.

Generate Biomedicines's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Dec. 2025 ))/ count )
=-203.154/( (518.259+330.182)/ 2 )
=-203.154/424.2205
=-47.89 %

Note: The Net Income data used here is one times the annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Generate Biomedicines's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Dec. 2025 ))/ count )
=31.893/( (518.259+330.182)/ 2 )
=31.893/424.2205
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Generate Biomedicines Total Assets Related Terms

Generate Biomedicines Total Assets Historical Data

* Premium members only.

The historical data trend for Generate Biomedicines's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generate Biomedicines Total Assets Chart

Generate Biomedicines Annual Data
Trend Dec24 Dec25
Total Assets
518.26 330.18

Generate Biomedicines Semi-Annual Data
Dec24 Dec25
Total Assets 518.26 330.18
GENB
6GF Score
Generate Biomedicines Inc GENB
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generate Biomedicines Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Generate Biomedicines's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=-623.197+953.379
=330.18

Generate Biomedicines's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=-623.197+953.379
=330.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $330.18 Mil mean?
Generate Biomedicines (GENB) has a Total Assets of $330.18 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Generate Biomedicines and its competitors.
Is Generate Biomedicines' Total Assets too high?
Generate Biomedicines' current Total Assets is $330.18 Mil. Overall, Generate Biomedicines has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Generate Biomedicines' Total Assets compare to PVLA and SLBT?
Generate Biomedicines' Total Assets of $330.18 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Generate Biomedicines and its competitors. Generate Biomedicines's current Total Assets is $330.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generate Biomedicines stock overvalued right now?
Generate Biomedicines (GENB) has a current Total Assets of $330.18 Mil. The current Total Assets is $330.18 Mil. Generate Biomedicines' overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Generate Biomedicines (GENB), the current Total Assets is $330.18 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Generate Biomedicines Business Description

Address 101 South Street, Suite 900, Somerville, MA, USA, 02143
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
6GF Score

Get the complete analysis for GENB

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.92
Price